| Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys R Shibata, T Igarashi, N Haigwood, A Buckler–White, R Ogert, W Ross, ... Nature medicine 5 (2), 204-210, 1999 | 711 | 1999 |
| Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells MW Cho, N Teterina, D Egger, K Bienz, E Ehrenfeld Virology 202 (1), 129-145, 1994 | 412 | 1994 |
| Biology of CCR5 and its role in HIV infection and treatment MM Lederman, A Penn-Nicholson, M Cho, D Mosier Jama 296 (7), 815-826, 2006 | 356 | 2006 |
| Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor DP Han, A Penn-Nicholson, MW Cho Virology 350 (1), 15-25, 2006 | 235 | 2006 |
| Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4 MW Cho, MK Lee, MC Carney, JF Berson, RW Doms, MA Martin Journal of virology 72 (3), 2509-2515, 1998 | 204 | 1998 |
| Mucosal Immunization with Surface-Displayed Severe Acute Respiratory Syndrome Coronavirus Spike Protein on Lactobacillus casei Induces Neutralizing … JS Lee, H Poo, DP Han, SP Hong, K Kim, MW Cho, E Kim, MH Sung, ... Journal of virology 80 (8), 4079-4087, 2006 | 196 | 2006 |
| N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and … RA Ogert, MK Lee, W Ross, A Buckler-White, MA Martin, MW Cho Journal of virology 75 (13), 5998-6006, 2001 | 186 | 2001 |
| Specific asparagine-linked glycosylation sites are critical for DC-SIGN-and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry DP Han, M Lohani, MW Cho Journal of virology 81 (21), 12029-12039, 2007 | 167 | 2007 |
| Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous simian/human … MW Cho, YB Kim, MK Lee, KC Gupta, W Ross, R Plishka, A Buckler-White, ... Journal of Virology 75 (5), 2224-2234, 2001 | 120 | 2001 |
| RNA duplex unwinding activity of poliovirus RNA-dependent RNA polymerase 3Dpol MW Cho, OC Richards, TM Dmitrieva, V Agol, E Ehrenfeld Journal of virology 67 (6), 3010-3018, 1993 | 118 | 1993 |
| Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T … RL Willey, R Shibata, EO Freed, MW Cho, MA Martin Journal of virology 70 (9), 6431-6436, 1996 | 97 | 1996 |
| Human immunodeficiency virus type 1 envelope gp120-induced partial T-cell receptor signaling creates an F-actin-depleted zone in the virological synapse G Vasiliver-Shamis, MW Cho, CE Hioe, ML Dustin Journal of virology 83 (21), 11341-11355, 2009 | 89 | 2009 |
| Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies YB Kim, DP Han, C Cao, MW Cho Virology 305 (1), 124-137, 2003 | 87 | 2003 |
| Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein DP Han, HG Kim, YB Kim, LLM Poon, MW Cho Virology 326 (1), 140-149, 2004 | 84 | 2004 |
| Human Immunodeficiency Virus Type 1 Envelope gp120 Induces a Stop Signal and Virological Synapse Formation in Noninfected CD4+ T Cells G Vasiliver-Shamis, M Tuen, TW Wu, T Starr, TO Cameron, R Thomson, ... Journal of virology 82 (19), 9445-9457, 2008 | 77 | 2008 |
| Determinants of protection among HIV-exposed seronegative persons: an overview MM Lederman, G Alter, DC Daskalakis, B Rodriguez, SF Sieg, G Hardy, ... The Journal of infectious diseases 202 (Supplement_3), S333-S338, 2010 | 69 | 2010 |
| Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations NL Teterina, WD Zhou, MW Cho, E Ehrenfeld Journal of virology 69 (7), 4245-4254, 1995 | 61 | 1995 |
| A structural landscape of neutralizing antibodies against SARS-CoV-2 receptor binding domain L Niu, KN Wittrock, GC Clabaugh, V Srivastava, MW Cho Frontiers in Immunology 12, 647934, 2021 | 59 | 2021 |
| Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells JE Vela Ramirez, R Roychoudhury, HH Habte, MW Cho, NLB Pohl, ... Journal of Biomaterials Science, Polymer Edition 25 (13), 1387-1406, 2014 | 56 | 2014 |
| Rapid completion of the replication cycle of hepatitis A virus subsequent to reversal of guanidine inhibition MW Cho, E Ehrenfeld Virology 180 (2), 770-780, 1991 | 55 | 1991 |
Adam Penn-NicholsonFoundation for Innovative New Diagnostics (FIND)Verified email at finddx.org
